Here's What Key Metrics Tell Us About U.S. Physical Therapy (USPH) Q1 Earnings

For the quarter ended March 2026, U.S. Physical Therapy (USPH) reported revenue of $198.29 million, up 7.9% over the same period last year. EPS came in at $0.46, compared to $0.48 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $203.5 million, representing a surprise of -2.56%. The company delivered an EPS surprise of -16.67%, with the consensus EPS estimate being $0.55.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how U.S. Physical Therapy performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Net rate per patient visit: $106.49 versus the two-analyst average estimate of $107.14.
  • Patient visits: 1,543,144 versus the two-analyst average estimate of 1,563,417.
  • Net revenue- Net patient: $164.33 million versus $167.5 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +7.7% change.
  • Net revenue- Other: $33.96 million versus the two-analyst average estimate of $33.99 million. The reported number represents a year-over-year change of +8.7%.

View all Key Company Metrics for U.S. Physical Therapy here>>>

Shares of U.S. Physical Therapy have returned -4.2% over the past month versus the Zacks S&P 500 composite's +10.3% change. The stock currently has a Zacks Rank #5 (Strong Sell), indicating that it could underperform the broader market in the near term.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."

Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

U.S. Physical Therapy, Inc. (USPH) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.